GE looks to sell its healthcare IT division

By Catherine Sturman
Share
Through receiving poor third quarter figures, General Electric are set to divest a number of its units and sell over $20 billion in assets, Reuters has...

Through receiving poor third quarter figures, General Electric are set to divest a number of its units and sell over $20 billion in assets, Reuters has recently reported.

Incorporating both API Healthcare and Centricity EMR, the company is also looking to divest its transportation business, but both divisions would need to be sub-divided upon the sale of the business units.

The sale would link with GE’s further ambitions to transform its service offering. It has previously sold its GE Capital business, as well as NBCUniversal, in order to place further investment in the areas presenting future growth and return on investment.

Related stories

However, the company has recently opened up a 3D printing lab in Sweden, as part of its focus on new healthcare technologies and development of new medical products. It joins GE Healthcare’s other advanced manufacturing and engineering centre in Milwaukee, Wisconsin. The two will collaborate, share knowledge and work on new design ideas.

Its advanced manufacturing engineering team has also developed and programmed multiple collaborative robots which are now installed in GE Healthcare factories globally and are improving efficiency in production lines.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare